Relevance of 24 H blood pressure profile and sympathetic activity for outcome on short-versus long-acting 1,4-dihydropyridines

American Journal of Hypertension

Volumn 9, Issue 1, 1996, Pages 86-94

  Ruzicka, Marcel ^a   Leenen, Frans H H ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

1,4 Dihydropyridines; Cardiac hypertrophy; Coronary artery disease

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; ISRADIPINE; METHYLDOPA; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITRENDIPINE; NORADRENALIN; VASODILATOR AGENT;

ADRENERGIC SYSTEM; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG FORMULATION; HEART DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SYMPATHETIC TONE;

ANIMALS; BLOOD PRESSURE DETERMINATION; CIRCADIAN RHYTHM; DIHYDROPYRIDINES; HUMANS; HYPERTENSION; RISK FACTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0030069475     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(95)00350-9     Document Type: Review

References (73)

1. Frattola A, Parati G, Cuspidi C, et al: Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
2. Rocco MB, Barry J, Campbell S, et al: Circadian variations of transient myocardial ischemia in patients with coronary artery disease. Circulation 1982;75:395-400.
3. Muller JE, Stone PH, Turi ZG, et al: Circadian variations in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-1322.
4. Shimada K, Kawamoto A, Matsubayashi K, et al: Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992;10:875-878.
5. Ruzicka M, Leenen FHH: Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, 2nd ed. Raven Press, Ltd., New York, 1995, pp 2815-2825.
6. Holzgreve H, Bürkle B: Anti-atherosclerotic effects of calcium antagonists. J Hypertens 1993;11(suppl 1):S55-S59.
7. Cruickshank JM, Lewis J, Moore V, et al: Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992;6:85-90.
8. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, et al: Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). Lancet 1990;335:1109-1113.
9. Waters D, Lespérance J, Francetich M, et al: A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990;82:1940-1953.
10. Thadani U, Zellner SR, Glasser S, et al: Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris. Circulation 1991;84:2398-2408.
11. The Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group: Early treatment of unstable angina in the coronary care unit: a randomized, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986;56:400-413.
12. Held PH, Yusuf S, Furberg CD: Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989;299:1187-119.
13. Yusuf S, Held PH, Furberg CD: Update of effects of calcium antagonists in myocardial infarction or angina in light of the Second Danish Verapamil Infarction Trial (DAVIT-11) and other recent studies. Am J Cardiol 1991; 67:1295-1297.
14. Struyker-Boudier HAJ, Smits JFM, De Mey JGR. The pharmacology of calcium antagonists: a review. J Cardiovasc Pharmacol 1990;15(suppl 4):S1-S10.
15. Kleinbloesem CH, van Brummelen P, van de Linde JA, et al: Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther 1984;35:742-749.
16. Kleinbloesem CH, van Brummelen P, Danhof M, et al: Rate-of-increase of plasma concentration of nifedipine as a major determinant of its haemodynamic effects in humans. Clin Pharmacol Ther 1987;41:26-30.
17. Edgar B, Collste P, Haglund K, et al: Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients. Clin Invest Med 1987;10: 388-394.
18. Myers MG, Raemsch KD: Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule. J Cardiovasc Pharmacol 1987;10(suppl 10):S76-S78.
19. Leenen FHH, Logan AG, Myers MG, et al: Antihypertensive efficacy of the calcium-antagonist felodipine in patients with persisting hypertension on β-adrenoreceptor blocker therapy. Br J Clin Pharmacol 1988;26: 535-545.
20. Leenen FHH, Holliwell DL: Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy. Am J Cardiol 1992;69:639-645.
21. Lederballe Pedersen O, Mikkelsen E, Christensen NJ, et al: Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension. Eur J Clin Pharmacol 1979;15:235-240.
22. Grossman E, Messerli FH, Oren S, et al: Cardiovascular effects of isradipine in essential hypertension. Am J Cardiol 1991;68:65-70.
23. Abernethy DR, Gutkowska J, Winterbottom LM: Effects of amlodipine, a long-acting dihydropyridine calcium antagonist in aging hypertension: pharmacodynamics in relation to disposition. Clin Pharmacol Ther 1990;48:76-86.
24. Mroczek WJ, Burris JF, Allenby KS: Effect of amlodipine on 24-hour ambulatory blood pressure in hypertensive patients. J Cardiovasc Pharmacol 1988;12(suppl 7):S79-S84.
25. Morris AD, Meredith PA, Reid JL: Pharmacokinetics of calcium antagonists: implications for therapy, in: Epstein M (ed): Calcium Antagonists in Clinical Medicine. Hanley & Belfus, Inc., Philadelphia, 1992, pp. 49-67.
26. Chung M, Reitberg DP, Gaffney M, et al: Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine. Am J Med 1987;83(suppl 6B):10-14.
27. Zanchetti A: Trough:peak ratio of the blood pressure response to dihydropyridine calcium antagonists. J Hypertens 1994;12(suppl 8):S97-S106.
28. Middlemost SJ, Sack M, Davis J, et al: Effects of long-acting nifedipine on casual office blood pressure measurements, 24-hour ambulatory blood pressure profiles, exercise parameters and left ventricular mass and function in black patients with mild to moderate systemic hypertension. Am J Cardiol 1992;70:474-478.
29. Lacourciere Y, Poirier L, Dion D, et al: Antihypertensive effect of isradipine administered once or twice daily on ambulatory blood pressure. Am J Cardiol 1990;65:467-472.
30. Arzilli F, Gandolfi E, Del Prato C, et al: Antihypertensive effect of once daily sustained release isradipine: a placebo controlled cross-over study. Eur J Clin Pharmacol 1993;44:23-25.
31. Fariello R, Boni E, Corda L, et al: Extended release felodipine in essential hypertension. Am J Hypertens 1991; 4:27-33.
32. Myers MG, Leenen FHH, Tanner J: Differential effects of felodipine and nifedipine on 24 hour blood pressure and left ventricular mass. Am J Hypertens 1995;8:712-718.
33. Tsoporis J, Fields N, Leenen FHH: Contrasting effects of calcium antagonists vs arterial vasodilators on cardiac anatomy and sympathetic activity in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1991; 17(suppl 2):S166-S168.
34. Kushiro T, Asagami T, Takahashi A, et al: Effects of long acting calcium channel blocker (CCB) and hydralazine on insulin sensitivity in spontaneously hypertensive rats (SHR) (abst). Am J Hypertens 1995;8:72A.
35. Fields N, Tsoporis J, Leenen FHH: Differential effects of the calcium antagonist, nisoldipine, versus the arterial vasodilator, minoxidil, on ventricular anatomy, intravascular volume, and sympathetic activity in rats. J Cardiovasc Pharmacol 1989;14:826-835.
36. Higuchi S, Takeshita A, Ito N, et al: Arterial pressure and heart rate responses to calcium channel blockers administered in the brainstem in rats. Circ Res 1985;57: 244-251.
37. Murphy MB, Scriven AJ, Brown MJ, et al: The effects of nifedipine and hydralazine induced hypotension on sympathetic activity. Eur J Clin Pharmacol 1982;23:479-482.
38. El-Beheiry H, Ruedy N, Wall RA, et al: The acute and chronic effects of nitrendipine on plasma catecholamines in hypertensive patients. Can J Cardiol 1993;9: 41-46.
39. Savonitto S, Bevilacqua M, Chebat E, et al: β-Adrenergic receptors and reflex tachycardia after single and repeated felodipine administration in essential hypertension. J Cardiovasc Pharmacol 1991;17:970-975.
40. Kiowski W, Bertel O, Erne P, et al: Hemodynamic and reflex responses to acute and chronic antihypertensive therapy with nifedipine. Hypertension 1983;5(suppl I): 70-74.
41. Muiesan G, Agabiti-Rosei E, Castellano M, et al: Anti-hypertensive and humoral effects of verapamil and nifedipine in essential hypertension. J Cardiovasc Pharmacol 1982;4(suppl 3):S325-S329.
42. Smith SA, Mace PJE, Littler WA: Felodipine, blood pressure, and cardiovascular reflexes in hypertensive humans. Hypertension 1986;8:1172-1178.
43. McLeay RAB, Stallard TJ, Watson RDS, et al: The effect of nifedipine on arterial pressure and reflex cardiac control. Circulation 1983;67:1084-1090.
44. Littler WA, Young MA: The effect of nicardipine on blood pressure, its variability and reflex cardiac control. Br J Clin Pharmac 1985;20:115S-119S.
45. Sleight P, Robinson JL, Brookes DE, et al: Characteristics of single carotid sinus baroreceptor fibers and whole nerve activity in the normotensive and the renal hypertensive dog. Circ Res 1977;41:750-758.
46. Dorward KPK, Andresen MC, Burke SL, et al: Rapid resetting of the aortic baroreceptors in the rabbit and its implications for short-term and longer term reflex control. Circ Res 1982;50:428-439.
47. Lindqvist M, Kahan T, Melcher A, et al: Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension. Hypertension 1994;24:287-296.
48. Halperin AK, Icenogle MV, Kapsner CO, et al: A comparison of the effects of nifedipine and verapamil on exercise performance in patients with mild to moderate hypertension. Am J Hypertens 1993;6:1025-1032.
49. Phillips RA, Ardeljan M, Shimabukuro S, et al: Effects of nifedipine-GITS on left ventricular mass and left ventricular filling. J Cardiovasc Pharmacol 1992:19 (suppl 2):S28-S34.
50. Julius S: Sympathetic hyperactivity and coronary risk in hypertension. Hypertension 1993;21:886-893.
51. Cohn JN: Sympathetic nervous system activity and the heart. Am J Hypertens 1989;2:353S-356S.
52. Lambert CR, Hill JA, Feldman RL, et al: Myocardial ischemia during intravenous nicardipine administration. Am J Cardiol 1985;55:844-845.
53. Waters D: Proischemic complications of dihydropyridine calcium channel blockers. Circulation 1991;84: 2598-2600.
54. I] Angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 1990;258:H806-H813.
55. 1-adrenergic receptor interaction: evidence for independent regulation of growth and beating. Circ Res 1985; 56:884-894.
56. Leenen FHH, Harmsen E: Antihypertensive drugs and cardiac trophic mechanisms. J Cardiovasc Pharmacol 1991;17(suppl 2):S50-S57.
57. Sen S, Tarazi RC: Regression of myocardial hypertrophy and influence of adrenergic system. Am J Physiol 1983;244:H97-H101.
58. Picca M, Pelosi GC: Effects of enalapril and amlodipine on left ventricular hypertrophy and function in hypertension. Eur Heart J 1992;13:P1056.
59. Fagard R, Lijnen P, Staessen J, et al: Mechanical and other factors relating to left ventricular hypertrophy. Blood pressure 1994;3(suppl 1)5-10.
60. Goldbourt U, Behar S, Reicher-Reiss H, et al: Early administration of nifedipine in suspected acute myocardial infarction. Arch Intern Med 1993;153:345-353.
61. Parmley WW, Nesto RW, Singh BN, et al: The N-CAP Study Group. Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. J Am Coll Cardiol 1992;19: 1380-1389.
62. Wallace WA, Wellington KL, Chess MA, et al: Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris. Am J Cardiol 1994;73:23-28.
63. Davies RF, Habibi H, Klinke WP, et al: Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol 1995;25:619-625.
64. Singh S: Long-term double-blind evaluation of amlodipine and nadolol in patients with stable exertional angina pectoris. Clin Cardiol 1993;16:54-58.
65. Taylor SH, Lee P, Jackson N, et al: A double-blind, placebo-controlled, parallel dose-response study of amlodipine in stable exertional angina pectoris. J Cardiovasc Pharmacol 1991;17(suppl 1):S46-S49.
66. Taylor SH: Usefulness of amlodipine for angina pectoris. Am J Cardiol 1994;73:28A-33A.
67. Bernink PJLM, de Weerd P, ten Cate FJ, et al: An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris. J Cardiovasc Pharmacol 1991;17(suppl I):S53-S56.
68. Ezekowitz MD, Hossack K, Mehta JL, et al: Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial. Am Heart J 1995;129:527-535.
69. Glasser SP, West TW: Clinical safety and efficacy of once-daily amlodipine for chronic stable angina pectoris. Am Heart J 1989;118:1127-1128.
70. Johnston DL, Lesoway R, Humen DP, et al: Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo controlled, double blind, randomised, crossover study. Am J Cardiol 1985; 55:680-687.
71. Findlay IN, MacLeod K, Ford M, et al: Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function. Br Heart J 1986;55:240-245.
72. Packer M: Combined beta-adrenergic and calcium-entry blockade in angina pectoris. N Engl J Med 1989; 320:709-718.
73. Gerstenblith G, Ouyang P, Achuff SC, et al: Nifedipine in unstable angina. A double-blind, randomized trial. N Engl J Med 1982;306:885-889.